Galvezo, Jhayfford .

HRN: 22-35-63  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/25/2022
12/31/2022
IVT
620mg
Q6
URTI
Waiting Final Action 
12/27/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/27/2022
01/02/2023
ORAL
5ml
Q8Hrs
URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: